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1. Introduction and aims 
 
Steroid derivatives are applied for clinical purposes worldwide. The halogen-
containing estrogens are useful for the treatment of estrogen-dependent breast 
cancer. The halogen-containing D-homosteroid derivatives are of great 
importance in the diagnosis and chemotherapy of human cancers. Moreover, 
the heterocyclic steroids are potential inhibitors of 17β-hydroxysteroid 
dehydrogenase, which transforms the estrone into estradiol. An other 
important area of clinical research is the study and application of androgens. 
 We have achieved the synthesis of bromo-containing estradiol 
derivatives by means of substitution reactions. Furthermore, our work on the 
ring-closure reactions of D-seco-steroids in the 13β and 13α series resulted in D-
homosteroids and D-heteroannulated compounds. Additionally, we have 
developed procedures for the synthesis of oxygen-, nitrogen- and sulphur-
containing ring D-modified steroids in the 13α series. 
 Our modifications of the estrone and androstane skeletons were 
performed with two aims: to study the chemo-, regio- and stereoselectivies of 
the reactions in the 13α and 13β series, and to synthetize novel, 




2. Methods applied 
 
Reactions were monitored by thin-layer chromatography. The substances 
produced were separated by flash chromatography. The structures of the 
compounds obtained were determined via the 1H and 13C NMR (J-MOD, NOE, 
NOESY and COSY) spectra, EI- and DCI-MS techniques, elemental analysis 
and single-crystal X-ray diffraction measurements.  
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3. Summary of the scientific achievements  
 
3.1. The reactions of the four isomers of 16-hydroxymethylestra-1,3,5(10)-
trien-17-ol (23a, 24a, 25, 26) with HBr and acetic acid in the 13β series 
proved to be stereospecific. The cis isomers (23a, 24a) were transformed 
via a six-membered acetoxonium cation into the 17-acetoxy-16-
bromomethyl derivatives (32a, 36a). The mechanism of the process can 
be interpreted as involving front-side neighbouring group participation. 
In contrast with the cis isomers (23a, 24a) under similar experimental 
conditions the trans isomers (25, 26) were converted into 17-acetoxy-16-
acetoxymethyl estradiol derivatives (37a, 39a), (Scheme 1). 
 
3.2. In the 13α series, treatment of the trans isomers of 16-hydroxymethyl-
13α-estra-1,3,5(10)-trien-17-ol (27, 28) with HBr and acetic acid furnished 
the 17-acetoxy-16-bromomethylestradiol derivatives (46, 50), similarly to 
the cis-isomers (23a, 24a), yielded 17-acetoxy-16-bromomethylestradiol 
derivatives (32a, 36a), in the 13β series. The mechanism of the process 
can likewise be interpreted as involving front-side neighbouring group 
participation.  
 
3.3. The cause of the lack of front-side neighbouring group participation in 
the reactions of the trans isomers in the 13β series is the steric hindrance 
of the methyl group on C-13. The steric position of this methyl group  
proved to have a significant effect on the reaction, as confirmed by 
study of the front-side neighbouring group participation in the 13α 
series.  
 
3.4. The trans isomers of 17-acetoxy-3-benzyloxy-16-bromomethylestra-
1,3,5(10)-triene (38b, 42b) in the 13β series were synthetized from the 
corresponding 16-hydroxymethylestra-1,3,5(10)-trien-17-ol (25, 26) via 
the APPEL reaction as a key step. 
 
3.5. Modification of the conditions of the above reactions of the four isomers 
of 16-hydroxymethylestra-1,3,5(10)-trien-17-ol (23a, 24a, 25, 26) allowed 
cleavage of the benzyl-protecting group. 17-Acetoxy-16-bromomethyl 
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group (32c, 36c, 38d, 42d) on C-3, and of 17-acetoxy-16-acetoxymethyl 
derivatives containing a hydroxy group (37b, 39b) or acetoxy group 
(37c, 39c) on C-3 were also synthetized.  
 
3.6. Debenzylation of the four isomers of 3-benzyloxy-16-bromomethylestra-
1,3,5(10)-trien-17-ol (32d, 36d, 38a, 42a) in the presence of Pd/C as 
catalyst resulted in the 16-bromomethyl estradiol derivatives (32e, 36e, 
38e, 42e). 
 
3.7. CLAISEN condensation of 3β-acetoxy-13α-androst-5-en-17-one (60b) with 
ethyl formate furnished the 16-hydroxymethylidene derivative 61a, 
which tautomerized into the 16-formyl compound 62. The 1H NMR 
spectrum demonstrated that 61a was the main form present in CDCl3 
(Scheme 2).  
 
3.8. The selective reduction of 3β-acetoxy-16-acetoxymethylidene-13α-
androst-5-en-17-one (61b) with NaBH4 afforded the two trans isomers of 
16-hydroxymethyl-13α-androst-5-en-17-one (63a, 63b). These products 
were separated after derivatization. 
 
3.9. For GROB fragmentation, the 16-iodomethyl derivatives (64b, 65) of the 
trans isomers of 16-hydroxymethyl-13α-androst-5-en-17-ol (63a, 63b) 
were synthetized by means of the APPEL reaction.  
 
3.10. Solvolysis of 3β-acetoxy-16α-iodomethyl-13α-androst-5-en-17β-ol (64b) 
under alkaline reaction conditions yielded the cis D-seco-steroid (66). As 
by-products, 16-methylidene (67) and 16-methoxymethyl (68) 
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3.11. The chemo-, regio- and stereoselective domino KNOEVENAGEL–
intramolecular hetero DIELS-ALDER (DK-IMHDA) reaction of the trans 
16,17-seco-aldehyde (83) in the 13β androstane series with N,N-
dimethylbarbituric acid (77a) and disubstituted pyrazol-5-one (80a-c) in 
the presence of EDDA as catalyst furnished 16α,17aα-substituted D-
homosteroid derivatives (84, 85). With 1,3-diphenylpyrazol-5-one as 
reagent (80c), we obtained the 16β,17aβ isomer (87) as a by-product 
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 Scheme 4 
 
3.12. The DK-IMHDA reaction in the 13α series was characterized by lower 
chemoselectivity than in the 13β series (Scheme 4). The stereoselective 
DK-IMHDA reaction of the cis 16,17-seco-aldehyde (66) with N,N-
dimethylbarbituric acid (77a) and disubsituted pyrazol-5-one reagents 
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(80a-d) in the presence of EDDA as catalyst gave the 16α,17α-
substituted D-heteroannulated derivatives (87, 89 and 92). The use of 3-
phenylisoxazol-5-one as reagent (91) yielded the 16β,17aβ-substituted 
bridged D-homosteroid (93) as a by-product. Under the reaction 
conditions of the DK-IMHDA reaction, unsaturated D-homosteroid 
derivatives (88, 90 and 94) were also formed. 
 
3.13. Differences in chemo- and regioselectivity of the DK-IMHDA reaction in 
the 13β and 13α series, were found to be caused by differences in 
structure flexibility of the sterane skeleton in the 13β and 13α series. 
 
3.14. In contrast with our expectation from the experiment in the 13β estrone 
series, the α-oxoketene dithioacetal (105) did not react with 
hydroxylamine (106) in the 13α androstene series; the 
izoxazolo[5’,4’:16,17]-13α-androst-5-en-17-one derivative was not 
formed (Scheme 5). The non-occurrence of the condensation of the 17-
keto function in the 13α series can be explained by steric hindrance of 
the methylthio group, caused by the modification in the sterane skeleton 
















 Scheme 5 
 
3.15. The α-oxoketene dithioacetal derivative (105) of 3β-hydroxy-13α-
androst-5-en-17-one (60a) is an excellent synthon for the synthesis of 
heterocycles. The condensations of 105 with hydrazine (96a), amidine 
(98c), benzidine (98d) and guanidine (98e) dinucleophile reagents gave 
steroid heterocycles containing a pyrazole (108) or pyrimidine (109a-c) 
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 Scheme 6 
 
3.16. The α-oxoketene dithioacetal derivative (105) of 3β-hydroxy-13α-
androst-5-en-17-one (60a) was transformed into the steroid derivative 
111 in the presence of NaOMe in methanol as solvent (Scheme 7).  
 













 Scheme 7 
 
3.17. The reactions of 16-hydroxymethylidene-13α-androst-5-en-17-one (61a) 
with substituted hydrazines (96a-g) proved to depend on the mono- or 
dinucleophile character of the reagent, which in turn depends on the 
electrophilic character of the substituent. With an aromatic ring bearing 
electron-donating substituents (CH3 and OCH3) or hydrogen, the 
hydrazine (96d, 96e, 96a) behaved as a dinucleophile, resulting in D-
heteroannulated derivatives (112c, 112d and 112a). Phenylhydrazine 
(96c) reacted as a mononucleophile and gave the 16a-phenylhydrazone 
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113a containing an unsaturated ring D. 2,4-Dinitrophenylhydrazine 
(96g) also reacted as a mononucleophile with 61a, and furnished 16a-
phenylhydrazone derivative 111f. p-Chlorophenylhydrazine (96f) has 
an ambivalent electronic character: as a dinucleophile, it gave the D-
heteroannulated derivative 112e, and as a mononucleophile, it gave the 
16a-(p-chlorophenyl)hydrazone derivative 113e containing an 
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3.18. The condensation of 16-hydroxymethylidene-13α-androst-5-en-17-one 
(61a) with phenylhydrazine yielded the D-heteroannulated derivatives 
112b only in the presence of a LEWIS acid catalyst. In the case of 2,4-
dinitrophenylhydrazine no reaction was observed in the presence of a 
LEWIS acid catalyst. 
 
3.19. An X-ray diffraction study of 3β-acetoxy-13α-androst-5-en-17-one (60b), 
α-oxoketene dithioacetal (105) and derivative 89c of cis 16,17-seco-
aldehyde confirmed that rings A and C of the sterane skeleton have a 
chair, ring B has a distorted half-chair, and the ring D has a 14β-
envelope conformation. This afforded an opportunity to study the 
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